The UAMS Myeloma Center is the most comprehensive center in the world for research and clinical care related to multiple myeloma and related diseases, such as Castleman Disease and Waldenstrom Macroglobulinemia. Our team of leading scientists and clinicians has pioneered many advances that have become standards of care, leading to improved survival rates. The Myeloma Center is known for its “bench to bedside” approach, continually translating advances in the laboratory into breakthrough clinical treatments.
We are committed to
- Accelerating curative therapies for multiple myeloma and related diseases through an integrated program of innovative research and high-quality, comprehensive patient care
- Customizing care based on each patient’s genetic profile and risk factors for truly personalized treatment
- Pushing the envelope of understanding and discovery to unravel the biology of multiple myeloma and maximize cure
Grateful Cancer Patient Pedals to Promote Myeloma CenterJanuary 16, 2020
David Sutton of St. Petersburg, Florida, was 42 and had an 18-month-old son when, on New Year’s Eve of 2004, he was diagnosed with myeloma and given a bleak prognosis from a cancer treatment center near his home.
Drag Racer, Specialty Mechanic Praises Treatment at Myeloma CenterNovember 12, 2019
“I was determined to find the best place I could go for treatment,” said drag racer and specialty mechanic Brian Macy, 49, of Lake Havasu City, Arizona, pictured here with wife Heather. Read more Drag Racer, Specialty Mechanic Praises Treatment at Myeloma Center Linda Haymes Nov. 12, 2019 | Drag racer and specialty mechanic Brian…
International Myeloma Foundation Partners with UAMS for Regional WorkshopNovember 5, 2019
UAMS Myeloma Center patients, caregivers and staff from across Arkansas and surrounding states spent a recent Saturday learning more about myeloma, a rare blood disease, and how to live successfully with it.